Wealth Alliance Advisory Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.54M Buy
6,285
+342
+6% +$349K 1.09% 21
2026
Q1
$5.47M Sell
5,943
-163
-3% -$165K 0.87% 27
2025
Q4
$6.56M Buy
6,106
+964
+19% +$922K 1.12% 22
2025
Q3
$3.92M Buy
5,142
+281
+6% +$209K 0.71% 32
2025
Q2
$3.79M Buy
4,861
+211
+5% +$164K 0.72% 32
2025
Q1
$3.84M Buy
4,650
+68
+1% +$56.6K 0.8% 27
2024
Q4
$3.54M Buy
4,582
+55
+1% +$45.5K 0.75% 28
2024
Q3
$4.01M Buy
4,527
+147
+3% +$132K 0.84% 24
2024
Q2
$3.97M Buy
4,380
+178
+4% +$142K 0.89% 23
2024
Q1
$3.27M Buy
4,202
+496
+13% +$353K 0.76% 24
2023
Q4
$2.16M Buy
3,706
+461
+14% +$269K 0.56% 35
2023
Q3
$1.74M Buy
3,245
+20
+0.6% +$10.3K 0.52% 36
2023
Q2
$1.51M Buy
3,225
+1,347
+72% +$565K 0.53% 35
2023
Q1
$645K Buy
1,878
+100
+6% +$33.7K 0.24% 69
2022
Q4
$650K Buy
1,778
+100
+6% +$35.5K 0.25% 64
2022
Q3
$543K Hold
1,678
0.24% 66
2022
Q2
$544K Buy
1,678
+3
+0.2% +$901 0.26% 67
2022
Q1
$480K Buy
1,675
+71
+4% +$18.3K 0.21% 79
2021
Q4
$443K Hold
1,604
0.19% 88
2021
Q3
$371K Hold
1,604
0.18% 89
2021
Q2
$368K Hold
1,604
0.18% 95
2021
Q1
$300K Hold
1,604
0.15% 105
2020
Q4
$271K Hold
1,604
0.15% 115
2020
Q3
$237K Hold
1,604
0.14% 105
2020
Q2
$263K Hold
1,604
0.16% 89
2020
Q1
$223K Hold
1,604
0.17% 95
2019
Q4
$211K Buy
+1,604
New +$186K 0.12% 124

Other funds holding LLY

Wealth Alliance Advisory Group's LLY Position: Q2 2026 in Review

Wealth Alliance Advisory Group increased its Eli Lilly (LLY) stake by 5.8% in Q2 2026, buying an estimated $349K and bringing the position to 6,285 shares worth $7.54M. The position accounts for 1.09% of the portfolio, ranked #21.

Wealth Alliance Advisory Group first reported a position in LLY in Q4 2019 and has held it in 27 quarters since. 1,691 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Wealth Alliance Advisory Group held 6,285 shares of Eli Lilly worth $7.54M as of Q2 2026.
  • Wealth Alliance Advisory Group bought 342 Eli Lilly shares in Q2 2026, an estimated $349K.
  • Eli Lilly made up 1.09% of Wealth Alliance Advisory Group's portfolio in Q2 2026, its #21 holding.
  • Wealth Alliance Advisory Group first reported a position in Eli Lilly in Q4 2019 and has held it in 27 quarters since.
  • 1,691 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Wealth Alliance Advisory Group's 13F filing for Q2 2026, filed 23 Jul 2026.